BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29137234)

  • 1. The AF4-MLL fusion transiently augments multilineage hematopoietic engraftment but is not sufficient to initiate leukemia in cord blood CD34
    Prieto C; Marschalek R; Kühn A; Bursen A; Bueno C; Menéndez P
    Oncotarget; 2017 Oct; 8(47):81936-81941. PubMed ID: 29137234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia.
    Montes R; Ayllón V; Gutierrez-Aranda I; Prat I; Hernández-Lamas MC; Ponce L; Bresolin S; Te Kronnie G; Greaves M; Bueno C; Menendez P
    Blood; 2011 May; 117(18):4746-58. PubMed ID: 21389315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells.
    Montes R; Ayllón V; Prieto C; Bursen A; Prelle C; Romero-Moya D; Real PJ; Navarro-Montero O; Chillón C; Marschalek R; Bueno C; Menendez P
    Leukemia; 2014 Mar; 28(3):666-74. PubMed ID: 24240202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
    Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P
    Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated KRAS Cooperates with MLL-AF4 to Promote Extramedullary Engraftment and Migration of Cord Blood CD34+ HSPC But Is Insufficient to Initiate Leukemia.
    Prieto C; Stam RW; Agraz-Doblas A; Ballerini P; Camos M; Castaño J; Marschalek R; Bursen A; Varela I; Bueno C; Menendez P
    Cancer Res; 2016 Apr; 76(8):2478-89. PubMed ID: 26837759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment.
    Lin S; Luo RT; Shrestha M; Thirman MJ; Mulloy JC
    Blood; 2017 Aug; 130(7):903-907. PubMed ID: 28637661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein.
    Bertrand FE; Vogtenhuber C; Shah N; LeBien TW
    Blood; 2001 Dec; 98(12):3398-405. PubMed ID: 11719380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic Leukemia.
    Lin S; Luo RT; Ptasinska A; Kerry J; Assi SA; Wunderlich M; Imamura T; Kaberlein JJ; Rayes A; Althoff MJ; Anastasi J; O'Brien MM; Meetei AR; Milne TA; Bonifer C; Mulloy JC; Thirman MJ
    Cancer Cell; 2016 Nov; 30(5):737-749. PubMed ID: 27846391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression.
    Dou L; Zheng D; Li J; Li Y; Gao L; Wang L; Yu L
    Oncogene; 2012 Jan; 31(4):507-17. PubMed ID: 21706045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs.
    Bueno C; Ayllón V; Montes R; Navarro-Montero O; Ramos-Mejia V; Real PJ; Romero-Moya D; Araúzo-Bravo MJ; Menendez P
    Blood; 2013 May; 121(19):3867-78, S1-3. PubMed ID: 23479570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel infant acute lymphoblastic leukemia cell line with MLL-AF5q31 fusion transcript.
    Imamura T; Morimoto A; Ikushima S; Kakazu N; Hada S; Tabata Y; Yagi T; Inaba T; Hibi S; Sugimoto T; Imashuku S
    Leukemia; 2002 Nov; 16(11):2302-8. PubMed ID: 12399976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-205 downregulates mixed-lineage-AF4 oncogene expression in acute lymphoblastic leukemia.
    Dou L; Li J; Zheng D; Li Y; Gao X; Xu C; Gao L; Wang L; Yu L
    Onco Targets Ther; 2013; 6():1153-60. PubMed ID: 24009426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4.MLL fusion allele.
    Kowarz E; Burmeister T; Lo Nigro L; Jansen MW; Delabesse E; Klingebiel T; Dingermann T; Meyer C; Marschalek R
    Leukemia; 2007 Jun; 21(6):1232-8. PubMed ID: 17410185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal liver Mll-AF4+ hematopoietic stem and progenitor cells respond directly to poly(I:C), but not to a single maternal immune activation.
    Malouf C; Ottersbach K
    Exp Hematol; 2019 Aug; 76():49-59. PubMed ID: 31381950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between
    Bueno C; Calero-Nieto FJ; Wang X; Valdés-Mas R; Gutiérrez-Agüera F; Roca-Ho H; Ayllon V; Real PJ; Arambilet D; Espinosa L; Torres-Ruiz R; Agraz-Doblas A; Varela I; de Boer J; Bigas A; Gottgens B; Marschalek R; Menendez P
    Haematologica; 2019 Jun; 104(6):1189-1201. PubMed ID: 30679325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by
    Secker KA; Bruns L; Keppeler H; Jeong J; Hentrich T; Schulze-Hentrich JM; Mankel B; Fend F; Schneidawind D; Schneidawind C
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517300
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
    Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
    Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute megakaryoblastic leukemia in a child with the MLL-AF4 fusion gene.
    Takita J; Motomura A; Koh K; Ida K; Taki T; Hayashi Y; Igarashi T
    Eur J Haematol; 2009 Aug; 83(2):149-53. PubMed ID: 19459927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthetic peptide PFWT disrupts AF4-AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells.
    Srinivasan RS; Nesbit JB; Marrero L; Erfurth F; LaRussa VF; Hemenway CS
    Leukemia; 2004 Aug; 18(8):1364-72. PubMed ID: 15269783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells
    Reimer J; Knöß S; Labuhn M; Charpentier EM; Göhring G; Schlegelberger B; Klusmann JH; Heckl D
    Haematologica; 2017 Sep; 102(9):1558-1566. PubMed ID: 28572162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.